Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31

Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30

$2.62−0.06 (-2.24%)

Close on Nov 13, 2026Market cap $91.08MP/E –Yield –

Anixa Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2012 it was 99.6%, against 96.6% the year before.

Period	Period end	Value	Change (pts)
FY2012	Oct 31, 2012	99.6%	+3.0
FY2011	Oct 31, 2011	96.6%	+7.9
FY2010	Oct 31, 2010	88.7%	–

See a number that looks wrong?